Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 921: WHO defines blindness as counting fingers at a distance of:

A. 1 meter
B. 3 meters (Correct Answer)
C. 6 meters
D. 9 meters

Explanation: **Explanation:** The World Health Organization (WHO) defines **blindness** as visual acuity of less than **3/60** (Snellen’s chart) or its equivalent in the better eye with best possible correction. In practical field conditions where Snellen’s charts are unavailable, this is clinically assessed as the inability to count fingers at a distance of **3 meters**. * **Why 3 meters is correct:** According to the WHO ICD-11 classification, "Blindness" (Vision Category 3, 4, and 5) starts when the patient cannot see the 3/60 line. Since the numerator (3) represents the distance from the chart, the bedside equivalent is counting fingers at 3 meters. * **Why other options are incorrect:** * **6 meters:** This represents the standard distance for normal visual acuity (6/6). * **1 meter:** This corresponds to "Severe Visual Impairment" (less than 1/60), but it is not the threshold for the definition of blindness itself. * **9 meters:** This distance does not correspond to any standard WHO diagnostic threshold for visual impairment. **High-Yield Clinical Pearls for NEET-PG:** 1. **WHO Definition of Blindness:** VA < 3/60 in the better eye. 2. **NPCB (National Programme for Control of Blindness - India) Definition:** India previously used < 6/60, but has now aligned with the WHO criteria of **< 3/60** to achieve the goals of "Vision 2020." 3. **Visual Impairment Categories:** * **Moderate:** < 6/18 to 6/60. * **Severe:** < 6/60 to 3/60. * **Blindness:** < 3/60 to No Light Perception. 4. **Most Common Cause:** Cataract remains the leading cause of blindness in India, followed by Refractive Errors.

Question 922: Which epidemiological study provides the most accurate results?

A. Meta-analysis (Correct Answer)
B. Cross-sectional study
C. Randomized controlled trial with double blinding
D. Cohort study

Explanation: ### Explanation The accuracy and reliability of epidemiological studies are determined by their position on the **Hierarchy of Evidence**. This hierarchy ranks study designs based on their ability to minimize bias and provide high-quality evidence for clinical decision-making. **1. Why Meta-analysis is correct:** A **Meta-analysis** sits at the pinnacle of the evidence pyramid. It is a statistical technique that combines data from multiple independent studies (usually Randomized Controlled Trials) to produce a single, high-power estimate of effect. By pooling results, it increases the sample size, reduces the margin of error, and resolves inconsistencies between individual studies, making it the most accurate and reliable source of evidence. **2. Why the other options are incorrect:** * **Randomized Controlled Trial (RCT) with double blinding:** While RCTs are the "Gold Standard" for primary research and provide strong evidence for causality, a single RCT is still subject to local biases and smaller sample sizes compared to a meta-analysis of multiple RCTs. * **Cohort Study:** This is an observational study. While excellent for determining incidence and risk factors, it is lower in the hierarchy than RCTs because it is more prone to confounding variables. * **Cross-sectional Study:** This study measures prevalence at a single point in time. It is at the bottom of the hierarchy for determining accuracy because it cannot establish a temporal relationship (cause-and-effect). **Clinical Pearls for NEET-PG:** * **Hierarchy of Evidence (Top to Bottom):** Meta-analysis > Systematic Review > RCT > Cohort > Case-Control > Cross-sectional > Case Series/Case Report. * **Systematic Review vs. Meta-analysis:** A systematic review is a qualitative summary of evidence; a meta-analysis is the **quantitative/statistical** component. * **Forest Plot:** The graphical representation used in a Meta-analysis to display the results of individual studies and the pooled estimate (represented by a diamond).

Question 923: What is the annual parasite index for a population of 100,000, among whom 100 cases were positive for malarial thick smear during a year?

A. 1 per 1000 (Correct Answer)
B. 2 per 1000
C. 10 per 1000
D. 20 per 1000

Explanation: ### Explanation **1. Understanding the Correct Answer (A)** The **Annual Parasite Index (API)** is a key epidemiological indicator used under the National Vector Borne Disease Control Programme (NVBDCP) to measure the incidence of malaria in a community. It is defined as the number of confirmed malaria cases (positive smears or RDTs) per 1,000 population per year. **Formula:** $$\text{API} = \frac{\text{Total number of positive slides for malaria in a year}}{\text{Total population under surveillance}} \times 1000$$ **Calculation for this question:** * Total positive cases = 100 * Total population = 100,000 * $\text{API} = (100 / 100,000) \times 1000 = \mathbf{1 \text{ per } 1000}$ **2. Why Other Options are Incorrect** * **Option B (2 per 1000):** This would require 200 positive cases in the same population. * **Option C (10 per 1000):** This would require 1,000 positive cases. * **Option D (20 per 1000):** This would require 2,000 positive cases. These values represent higher transmission intensities than the data provided. **3. High-Yield Clinical Pearls for NEET-PG** * **API Significance:** An API of **$\geq$ 2** is the critical threshold used to identify "high-risk" areas for malaria in India, triggering intensified control measures like Indoor Residual Spraying (IRS). * **Annual Blood Examination Rate (ABER):** This measures the efficiency of the surveillance system. For a surveillance program to be considered effective, the ABER should be at least **10%** (meaning 10% of the population is screened annually). * **Slide Positivity Rate (SPR):** Unlike API (which uses the total population), SPR is the percentage of examined slides that are positive for malaria. * **Slide Falciparum Rate (SFR):** The number of *P. falciparum* cases per 1,000 population.

Question 924: Which one of the following is true regarding case fatality rate?

A. The numerator represents the number of deaths from a specific disease.
B. The denominator represents the total population at risk.
C. The numerator and denominator are proportional to each other.
D. The numerator and denominator are distinct components that define the rate. (Correct Answer)

Explanation: **Explanation** **Case Fatality Rate (CFR)** is a measure of the severity or virulence of a disease. It represents the proportion of people diagnosed with a specific disease who die from that disease within a specified period. **Why Option D is Correct:** In epidemiology, a **ratio** consists of a numerator and a denominator that are distinct (the numerator is not necessarily part of the denominator), whereas a **proportion** implies the numerator is a subset of the denominator. Although commonly called a "rate," CFR is technically a **proportion**. Option D correctly identifies that the numerator (deaths from disease X) and denominator (total cases of disease X) are the two distinct components that define this specific metric. **Analysis of Incorrect Options:** * **Option A:** While the numerator does represent deaths from a specific disease, this statement is incomplete as it doesn't define the relationship with the denominator, which is the defining characteristic of CFR. * **Option B:** This is the definition of **Cause-Specific Mortality Rate**. In CFR, the denominator is the **total number of cases** of the disease, not the total population at risk. * **Option C:** In a proportion (which CFR is), the numerator is always a part of the denominator. Saying they are "proportional to each other" is a vague mathematical description that does not accurately define the epidemiological structure of a rate or proportion. **High-Yield Clinical Pearls for NEET-PG:** * **Formula:** $\text{CFR} = \frac{\text{Total deaths from a disease}}{\text{Total number of cases of that disease}} \times 100$. * **Significance:** CFR reflects the **killing power** or **virulence** of a pathogen. * **Complement:** CFR is the complement of the **survival rate** (Survival Rate = 100 – CFR). * **Time Frame:** CFR is typically used for acute infectious diseases (e.g., Rabies has a CFR of nearly 100%). It is less useful for chronic diseases where the duration of illness is long.

Question 925: Which of the following parasitic infections is characterized by a cyclodevelopmental stage?

A. Malaria
B. Filaria (Correct Answer)
C. Plague
D. Cholera

Explanation: In vector-borne diseases, the relationship between the parasite and the vector is classified based on whether the parasite multiplies or undergoes structural changes within the host. **Explanation of the Correct Answer:** **Filaria (Option B)** is the classic example of **Cyclodevelopmental** transmission. In this stage, the parasite undergoes essential developmental changes (e.g., microfilariae maturing into L1, L2, and infective L3 larvae) within the mosquito vector, but there is **no multiplication** in numbers. One microfilaria ingested results in only one infective larva. **Analysis of Incorrect Options:** * **Malaria (Option A):** Exhibits **Cyclo-propagative** transmission. The *Plasmodium* parasite undergoes both developmental changes (gametocyte to sporozoite) and significant multiplication (sporogony) within the female Anopheles mosquito. * **Plague (Option C):** Exhibits **Propagative** transmission. The *Yersinia pestis* bacteria simply multiply within the gut of the rat flea without undergoing any cyclic changes or metamorphosis. * **Cholera (Option D):** This is a water-borne/fecal-oral disease, not a vector-borne parasitic infection. It does not involve biological transmission through an arthropod vector. **High-Yield Clinical Pearls for NEET-PG:** 1. **Propagative:** Multiplication only (e.g., Plague, Yellow Fever, Dengue). 2. **Cyclodevelopmental:** Development only; no multiplication (e.g., Filaria, Guinea worm). 3. **Cyclo-propagative:** Both development and multiplication (e.g., Malaria). 4. **Transovarial Transmission:** When the pathogen is passed to the next generation of vectors via eggs (e.g., Scrub typhus/Trombiculid mites, Kyasanur Forest Disease/Ticks).

Question 926: A city has a population of 10000 with 500 diabetic patients. A new diagnostic test is applied to this population. The test gives a true positive result in 350 patients and a false positive result in 1900 patients. Which of the following statements regarding the test are true?

A. Prevalence is 5%, Sensitivity is 70%, Specificity is 80% (Correct Answer)
B. Sensitivity is 70%, Specificity is 80%
C. Prevalence is 5%, Sensitivity is 70%, Specificity is 70%
D. Sensitivity is 70%, Specificity is 70%

Explanation: To solve this problem, we must first organize the data into a **2x2 contingency table**. **Given Data:** * Total Population ($N$) = 10,000 * Total Diseased ($D+$) = 500 (Diabetic patients) * Total Non-diseased ($D-$) = $10,000 - 500 = 9,500$ * True Positives ($TP$) = 350 * False Positives ($FP$) = 1,900 ### 1. Calculations * **Prevalence:** (Total cases / Total population) × 100 * $500 / 10,000 \times 100 = \mathbf{5\%}$ * **Sensitivity:** (True Positives / Total Diseased) × 100 * $350 / 500 \times 100 = \mathbf{70\%}$ * **Specificity:** (True Negatives / Total Non-diseased) × 100 * First, find True Negatives ($TN$): $9,500 (Total\ D-) - 1,900 (FP) = 7,600$ * $7,600 / 9,500 \times 100 = \mathbf{80\%}$ ### 2. Analysis of Options * **Option A is correct** because it accurately reflects all three calculated parameters. * **Option B** is incomplete as it omits the prevalence, which is a key epidemiological metric requested by the context of the question. * **Options C and D** are incorrect because they state a specificity of 70%. A specificity of 70% would imply 2,850 false positives ($9,500 \times 0.30$), which contradicts the provided data of 1,900. ### 3. NEET-PG High-Yield Pearls * **Sensitivity (SNoP):** Sensitivity rules **OUT** the disease when the test is negative. It is the ability of a test to identify true cases. * **Specificity (SPiN):** Specificity rules **IN** the disease when the test is positive. It is the ability to identify those without the disease. * **Prevalence:** Unlike sensitivity and specificity, **Predictive Values (PPV/NPV)** are heavily dependent on the prevalence of the disease in the population. As prevalence increases, PPV increases and NPV decreases.

Question 927: Which of the following diseases does not exhibit seasonal variation?

A. Measles
B. Rubella
C. Gastroenteritis
D. None of the above (Correct Answer)

Explanation: ### Explanation The correct answer is **D. None of the above**, because all three diseases listed (Measles, Rubella, and Gastroenteritis) exhibit distinct **seasonal variations** in their incidence. Seasonal variation refers to the regular fluctuation in the occurrence of a disease within a calendar year, often driven by environmental factors, host behavior, or vector prevalence. **Analysis of Options:** * **Measles (Option A):** Measles typically shows a peak in incidence during the **late winter and spring** months. In tropical areas, the peak often coincides with the dry season. This is due to increased indoor crowding and environmental conditions favoring the survival of the virus. * **Rubella (Option B):** Similar to measles, Rubella is a respiratory viral infection that exhibits a strong seasonal pattern, peaking during the **spring** (March to May in the Northern Hemisphere). * **Gastroenteritis (Option C):** This exhibits a "bimodal" seasonality depending on the causative agent. **Bacterial gastroenteritis** (e.g., Cholera, Salmonellosis) typically peaks during the **hot and rainy/monsoon** months, while **viral gastroenteritis** (e.g., Rotavirus) is famously known as "winter diarrhea" due to its peak in **colder months**. **High-Yield Clinical Pearls for NEET-PG:** * **Cyclic Trend:** Measles also shows a cyclic trend (epidemics every 2–3 years) in unvaccinated populations. * **Leading Question Tip:** If a question asks for a disease with *no* seasonal variation, look for chronic non-communicable diseases (like Hypertension) or diseases with a constant environmental source (like certain fungal infections), though most infectious diseases follow some seasonal pattern. * **Vector-borne diseases:** Always remember that Malaria and Dengue peak during/after the monsoon due to increased breeding sites for mosquitoes.

Question 928: Incubation period knowledge helps in all of the following except:

A. Isolation (Correct Answer)
B. Quarantine
C. Detecting source of infection
D. Vaccination

Explanation: ### Explanation The correct answer is **Isolation** because it is based on the **period of communicability**, not the incubation period. #### 1. Why Isolation is the Correct Answer **Isolation** is the separation of **infected persons** (cases) from others for the duration of the period of communicability to prevent the direct or indirect transmission of the infectious agent. Since the person is already showing symptoms or is a confirmed case, the incubation period (the time from exposure to the onset of symptoms) has already passed. Therefore, knowledge of the incubation period is not required to initiate isolation. #### 2. Analysis of Other Options * **Quarantine:** This is the limitation of movement of **healthy persons** who have been exposed to a disease. Quarantine is applied for a duration equal to the **longest known incubation period** of the disease to see if they develop symptoms. * **Detecting Source of Infection:** By knowing the incubation period, clinicians can trace back in time from the onset of symptoms to identify when and where the patient was likely exposed, helping pinpoint the source (e.g., a contaminated food source in a point-source outbreak). * **Vaccination:** Knowledge of the incubation period helps determine the effectiveness of **post-exposure prophylaxis**. For diseases with long incubation periods (e.g., Rabies, Hepatitis B), active vaccination after exposure can induce immunity before the disease manifests. #### 3. NEET-PG High-Yield Pearls * **Quarantine:** Applied to healthy/exposed persons; duration = **Maximum** incubation period. * **Isolation:** Applied to sick/infected persons; duration = **Period of communicability**. * **Median Incubation Period:** The time required for 50% of the cases to occur following exposure. * **Extrinsic Incubation Period:** The time taken for the pathogen to develop inside the **vector** (e.g., Malaria parasite in the mosquito).

Question 929: What criterion is used to declare an area as free of an epidemic?

A. No new case reported for twice the incubation period of the disease since the last case (Correct Answer)
B. No new case reported for the incubation period of the disease since the last case
C. Till the last secondary case recovers
D. No new case reported for six months since the last case

Explanation: ### Explanation **1. Why Option A is Correct:** The standard epidemiological criterion for declaring an epidemic over is the absence of new cases for a duration of **twice the maximum incubation period** of the disease, starting from the date of onset of the last known case. * **The Logic:** This "double incubation period" rule ensures that even if a subclinical or missed case existed, any potential secondary transmission from that case would have manifested clinically. It provides a statistical safety margin to account for variations in the incubation period and ensures that the chain of transmission is truly broken. **2. Why Other Options are Incorrect:** * **Option B:** Waiting for only one incubation period is insufficient. A case could still be in the late stages of incubation or could have transmitted the infection to another person who has not yet shown symptoms. * **Option C:** The recovery of the last case does not account for the potential "silent" transmission occurring in the community during that patient's infectious period. * **Option D:** Six months is an arbitrary timeframe. Epidemiological surveillance must be disease-specific, as incubation periods vary significantly (e.g., days for Cholera vs. weeks for Hepatitis A). **3. High-Yield NEET-PG Pearls:** * **Incubation Period:** The time interval between the invasion by an infectious agent and the appearance of the first sign or symptom of the disease. * **Median Incubation Period:** Determined from the **Point Source Epidemic Curve** (time from exposure to the peak of the curve). * **Quarantine:** The duration of quarantine is typically the **maximum incubation period** of the disease. * **Generation Time:** The interval between receipt of infection and maximal infectivity (often shorter than the incubation period in diseases like Measles).

Question 930: In dengue infection, what is the expected number of petechial spots per square inch in the cubital fossa?

A. >5
B. >10
C. >15
D. >20 (Correct Answer)

Explanation: This question pertains to the **Hess Test** (also known as the **Tourniquet Test**), a clinical diagnostic tool used to assess capillary fragility and a key criterion in the WHO classification of Dengue Hemorrhagic Fever (DHF). ### **Explanation of the Correct Answer** The correct answer is **>20 (Option D)**. According to the WHO guidelines for the management of Dengue, a tourniquet test is considered **positive** if **20 or more petechiae** are observed per 1 square inch (6.25 cm²) area, usually on the volar aspect of the forearm or the cubital fossa. **The Procedure:** 1. Inflate a blood pressure cuff to a point midway between the systolic and diastolic pressures (Mean Arterial Pressure). 2. Maintain this pressure for 5 minutes. 3. Deflate and wait 2 minutes for skin color to return to normal. 4. Count the number of petechiae in a 1-inch square area. ### **Analysis of Incorrect Options** * **Options A, B, and C (>5, >10, >15):** These values are below the standardized diagnostic threshold. While any petechiae indicate some degree of capillary fragility, they do not meet the specific WHO criteria for a "positive" test in the context of Dengue. ### **High-Yield Clinical Pearls for NEET-PG** * **Significance:** A positive tourniquet test suggests **capillary fragility** and **thrombocytopenia**. It is often the only hemorrhagic manifestation in the early stages of Dengue. * **WHO Criteria:** It is one of the four clinical components required for the diagnosis of DHF (along with fever, hemorrhagic tendencies, and plasma leakage). * **Sensitivity:** The test has high specificity but variable sensitivity; a negative test does **not** rule out Dengue. * **Dengue Triad:** Fever, rash, and severe body ache ("Break-bone fever"). * **Vector:** *Aedes aegypti* (Daytime biter, breeds in artificial collections of clean water).

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free